Protection throughout the life span: The psychoneuroimmunologic impact of Indo-Tibetan meditative and yogic practices

Annals of the New York Academy of Sciences

Volumn 1172, Issue , 2009, Pages 163-171

  Olivo, Erin L ^a  

^a Department of Psychiatry ^*  (United States)

Author keywords

Meditation; Preventative health; Psychoneuroimmunology

Indexed keywords

AGING; COGNITION; CONFERENCE PAPER; HEALTH SERVICE; IMMUNE RESPONSE; LEISURE; LIFESPAN; LONGEVITY; MEDICAL RESEARCH; NEUROENDOCRINE SYSTEM; PSYCHOPHYSIOLOGY; STRESS;

EID: 69549084713     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04415.x     Document Type: Conference Paper

References (101)

1. Avedon, J.F. 1998. The Buddha's Art of Healing: Tibetan Paintings Rediscovered. Rizzoli. New York.
2. Chung, H.Y., H.J. Kim, K.W. Kim, et al. 2002. Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc. Res. Tech. 59 : 264 272.
3. Effros, R.B. 2001. Ageing and the immune system. Novartis Found Symp. 235 : 130 139, discussion 139-145, 146-149.
4. Ershler, W. & E. Keller. 2000. Age associated increased interleukin-6 gene expression, late life diseases, and frailty. Annu. Rev. Med. 51 : 245 270.
5. Tracey, K.J. 2002. The inflammatory reflex. Nature 420 : 853 859.
6. Weber, C., P. Arck, B. Mazurek & B.F. Klapp. 2002. Impact of a relaxation training on psychometric and immunologic parameters in tinnitus sufferers. J. Psychosom. Res. 52 : 29 33.
7. Wood, G.J. et al. 2003. Hypnosis, differential expression of cytokines by T cell subsets, and the hypothalamo-pituitary-adrenal axis. Am. J. Clin. Hypn. 45 : 179 196.
8. Carlson, L.E. et al. 2003. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosom. Med. 65 : 571 581.
9. Jones, B.M. 2001. Changes in cytokine production in healthy subjects practicing Guolin Qigong: a pilot study. BMC Complement. Altern. Med. 1 : 8 12.
10. Laidlaw, T.M. et al. 1996. Reduction in skin reactions to histamine after a hypnotic procedure. Psychosom. Med. 58 : 242 248.
11. Lutgendorf, S. et al. 2000. Effects of relaxation and stress on the capsaicin-induced local inflammatory response. Psychosom. Med. 62 : 524 534.
12. Smith, G.R. et al. 1985. Psychologic modulation of the human immune response to varicella zoster. Arch. Intern. Med. 145 : 2110 2112.
13. Zachariae, R. et al. 1994. Effects of hypnotic suggestions on ultraviolet B radiation-induced erythema and skin blood flow. Photodermatol. Photoimmunol. Photomed. 10 : 154 160.
14. Mori, E., M. Hashimoto, K.R. Krishnama & P.M. Doraiswamy. 2006. What constitues clinical evidence of neuroprotection in Alzheimer disease. Support for the cholinesterase inhibitors? Alzeheimer Dis. Assoc. Disord. 20 (Suppl 1 S19 S26.
15. Doraiswamy, P.M. & M.M. Husain. 2006. Anticholinergic drugs and elderly people: a no brainer? Lancet 5 : 379 380.
16. Ewin, D.M. 1978. Relieving suffering-and pain-with hypnosis. Geriatrics 33 : 87 89.
17. Zachariae, R. et al. 1990. The effect of hypnotically induced analgesia on flare reaction to the cutaneious histamine prick test. Arch. Dermatol. Res. 282 : 539 543.
18. Deleted in press.
19. Blumenfield, M. & M. Schoeps. 1992. Reintegrating the healed burned adult into society: psychological problems and solutions. Clin. Plast. Surg. 19 : 599 605.
20. Das, N.N. & H. Gastaut. 1955. Variations de l'activite electrique du cerveau, du coeur et des muscles squelettiques au cours de la meditation et de l'extase yogique. EEG Clin Neurophysiol. (Suppl 6 211 219.
21. Hoenig, J. 1968. Medical research on Yoga. Confina Psychiatrica 11 : 69 89.
22. Kasamatsu, A. & T. Hirai. 1966. An electroencephalographic study on the Zen Meditation (Zazen). Folia Psychiatrica et Neurologica Japonica 20 : 315 336.
23. Larbig, W. et al. 1982. EEG and slow brain potentials during anticipation and control of painful stimulation. EEG Clin. Neurophysiol. 53 : 298 309.
24. Pelletier, K.R. & E. Peper. 1977. Developing a biofeedback model: Alpha EEG as a means for pain control. Int. J. Clin. Exp. Hypnosis 25 : 361 371.
25. Anand, B.K., G.S. Chhina & B. Singh. 1961. Studies on Shri Ramanand Yogi during his stay in an airtight box. Indian J. Med. Res. 49 : 82 89.
26. Anand, B.K., G.S. Chhina & B. Singh. 1961. Some aspects of electroencephalographic studies in yogis. EEG Clin. Neurophysiol. 13 : 452 456.
27. th International Advanced Ethiopian Studies, Addis Ababa, Ethiopia, Apri 1991. In: Beyene T. et al., (eds.) Proceedings of the Eleventh International Conference of Ethiopian Studies. Addis Ababa University Press.
28. Massion, A.O. et al. 1995. Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data. Med. Hypotheses 44 : 39 46.
29. Coker, K.H. 1999. Meditation and prostate cancer: integrating a mind/body intervention with traditional therapies. Semin. Urol. Oncol. 17 : 111 118.
30. Tooley, G.A. et al. 2000. Acute increases in night-time melatonin levels following a period of meditation. Biol. Psychol. 53 : 69 78.
31. Schneider, R.S. et al. 1989. Serum dehydroepiandrosterone sulfate (DHEAS) levels in Transcendental Meditation practitioners. Psychosom. Med. 51 : 256.
32. Glaser, J.L. et al. 1992. Elevated serum dehydroepiandrosterone levels in practitioners of the Transcendental Meditation and TM-Sidhi programs. J Behav. Med. 15 : 327 341.
33. MacLean, C.R.K. et al. 1993. Apparent serum dehydroepiandrosterone response to acute laboratory stress. Soc. Neurosci. Abstr. 19 : 169.
34. Khalsa, G.S. & J.N.S. Khalsa. 1976. Study of hormonal changes (Prl, GH, LH) in two Kundalini meditations. Unpublished paper, Kundalini Research Institute.
35. Ryu, H. et al. 2000. Modulation of neuroendocrinological function by psychosomatic training: acute effect of ChunDoSunBup Qi-training on growth hormone, insulin-like growth factor (IGF)-1, and insulin-like growth factor binding protein (IGFBP)-3 in men. Psychoneuroendocrinology 25 : 439 451.
36. Cuzzocrea, S. & R.J. Reiter. 2001. Pharmacological action of melatonin in shock, inflammation, and ischemia/reperfusion injury. Eur. J. Pharmacol. 426 : 1 10.
37. Cuzzocrea, S. & R.J. Reiter. 2002. Pharmacological actions of melatonin in acute and chronic inflammation. Curr. Topics Med. Chem. 2 : 153 165.
38. Ben-Nathan, D. et al. 1999. Androstenediol and dehydroepiandrosterone protects mice against lethal bacterial infections and lipopolysaccharide toxicity. J. Med. Microbiol. 48 : 425 431.
39. Angele, M.K. et al. 1998. Dehydroepiandrosterone: an inexpensive steroid hormone that decreases the mortality due to sepsis following trauma-induced hemorrhage. Arch. Surg. 133 : 1281 1288.
40. Straub, R.H. et al. 2002. Dehydroepiandrosterone in relation to other adrenal hormones during an acture inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumor necrosis factor. Eur. J. Endocrinol. 146 : 365 374.
41. Sesmilo, G. et al. 2000. Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann. Intern. Med. 133 : 111 122.
42. Van Den Berghe, G. et al. 2001. Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology 26 : 591 612.
43. Catania, A. et al. 2000. Plasma concentrations and anti-L-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit. Care Med. 28 : 1403 1407.
44. Getting, S.J. 2002. Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy. Trends Pharmacol. Ther. 23 : 447 449.
45. Oktar, B.K. & I. Alican. 2002. Modulation of the peripheral and central inflammatory responses by alpha-melanocyte stimulating hormone. Curr. Protein Pept. Sci. 3 : 623 628.
46. Ben-Nathan, D. et al. 1995. Protective effects of melatonin in mice infected with encephalitis viruses. Arch. Virol. 140 : 223 230.
47. El-Sokkary, G.H. et al. 2002. Melatonin reduces oxidative damage and increases survival of mice infected with Schistosoma mansoni. Free Radic. Biol. Med. 23 : 319 332.
48. Hernandez-Pando, R. et al. 1998. The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. Immunology 95 : 234 241.
49. Ader, R., N. Choen & D.L. Felten. 1995. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 345 : 99 103.
50. Ader, R., D.L. Felten & N. Cohen. 2001. Psychoneuroimmunology, 3rd edition. Academic Press. New York.
51. Cohen, S. et al. 1998. Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychology 17 : 214 223.
52. Rozanski, A., J.A. Blumenthal & J. Kaplan. 1999. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99 : 2192 2217.
53. Kop, W.J. 1999. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosom. Med. 61 : 476 487.
54. Hemingway, H. & M. Marmot. 1999. Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ 318 : 110 112.
55. Mohr, D.C., S.L. Hart, L. Julian, et al. 2004. Association between stressful life events and exacerbation of multiple sclerosis: a meta-analysis. BMJ 328 : 731.
56. Rovner, B.W., P.S. German, L.J. Brant, et al. 1991. Depression and mortality in nursing homes. JAMA 265 : 993 996.
57. Anda, R., D. Williamson, D. Jones, et al. 1993. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 4 : 285 294.
58. Bruce, M.L., P.J. Leaf, G.P.M. Rozal, et al. 1994. Psychiatric status and 9-year mortality data in the New Haven epidemiologic catchment area study. Am. J. Psychiatry 151 : 716 721.
59. Morris, P.L.P., R.G. Robinson, P. Andrzejewski, et al. 1993. Association of depression with 10 year post-stroke mortality. Am. J. Psychiatry 150 : 124 129.
60. Frasure-Smith, N., F. Lesperance & M. Talajic. 1995. Depression and 18 month prognosis after myocardial infarction. Circulation 91 : 999 1005.
61. Epel, E.S. et al. 2004. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. USA 101 : 17312 17315.
62. Epel, E.S. et al. 2006. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology 31 : 277 287.
63. Sapolsky, R.M. 2004. Organismal stress and telomeric aging: an unexpected connection. Proc. Natl. Acad. Sci. USA 101 : 17323 17324.
64. Kabat-Zinn, J. 1990. Full Catastrophe Living. Using the Wisdom ofY Body and Mind to Face Stress, Pain and Illness. Bantam Doubleday Dell Publishing. New York.
65. Baer, R.A. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin. Psychol. Sci. Pract. In Press.
66. Bishop, S.R. 2002. What do we really know about mindfulness-based stress reduction? Psychosom. Med. 64 : 71 84.
67. Astin, J. 1997. Stress reduction through mindfulness meditation: effects on psychological symptomatology, sense of control, and spiritual experiences. Psychother. Psychosom. 66 : 97 106.
68. Shapiro, S.L., G.E. Schwartz & G. Bonner. 1998. Effects of mindfulness-based stress reduction on medical and premedical students. J. Behav. Med. 8 : 163 190.
69. Williams, K.A., M.M. Kolar, B.E. Reger & J.C. Pearson. 2001. Evaluation of a wellness-based mindfulness stress reduction intervention: a controlled trial. Am. J. Health Promot. 15 : 422 432.
70. Speca, M., L. Carlson, E. Goodey & M. Angen. 2000. A randomized wait-list controlled trial: the effects of a mindfulness-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom. Med. 62 : 613 622.
71. Teasdale, J.D., Z.V. Segal, J.M.G. Williams, et al. 2000. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J. Consult. Clin. Psychol. 68 : 615 623.
72. Kabat-Zinn, J. 1982. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen. Hosp. Psychiatry 4 : 33 47.
73. Kabat-Zinn, J., L. Lipworth & R. Burney. 1985. The clinical use of mindfulness meditation for the self regulation of chronic pain. J. Behav. Med. 8 : 163 190.
74. Kabat-Zinn, J., L. Lipworth, R. Burney & W. Sellers. 1987. Four-year follow-up of a meditation based program for the self regulation of chronic pain: treatment outcome and compliance. Clin. J. Pain. 2 : 159 173.
75. Kabat-Zinn, J., A.O. Massion, J. Kristellar, et al. 1992. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am. J. Psychiatry 149 : 936 943.
76. Miller, J.J., K. Fletcher & J. Kabat-Zinn. 1995. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen. Hosp. Psychiatry 17 : 192 200.
77. Waelde, L.C. et al. 2004. A pilot study of a yoga and meditation intervention for dementia caregiver stress. J. Clin. Psychol. 60 : 677 687.
78. McEwan, B.S. 1999. Stress and the aging hippocampus. Front. Neuroendocrinol. 20 : 49 70.
79. Seeman, T.E., B.H. Singer, J.W. Rowe, et al. 1997. Price of adaptation-allostatic load and its health consequences. MacArthur studies of successful aging. Arch. Intern. Med. 157 : 2259 2268.
80. Jevning, R., A.F. Wilson & M.J. Davidson. 1978. Adrenocortical activity during meditation. Horm. Behav. 10 : 54 60.
81. MacLean, C.R.K., K.G. Walton, S.R. Wenneberg, et al. 1997. Effects of the transcendental meditation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrin 22 : 277 295.
82. Werner, O.R., R.K. Wallace, B. Charles, et al. 1986. Long term endocrinologic changes in subjects practicing the transcendental meditation and TM-Sidhi program. Psychosom. Med. 48 : 59 66.
83. Walton, K.G. et al. 2004. Lowering cortisol and CVD risk in postmenopausal women: a pilot study using the transcendental meditation program. Ann. N. Y. Acad. Sci. 1032 : 211 215.
84. Borovikova, L.V. et al. 2000. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 : 458 462.
85. Tracey, K.J. et al. 2001. Mind over immunity. FASEB J. 15 : 1575 1576.
86. Bernik, T.R. et al. 2002. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195 : 781 786.
87. De Backer, D. et al. 2002. Microvascular blood flow is altered in patients with sepsis. Am. J. Respir. Crit. Care Med. 166 : 98 104.
88. MacLean, C.R.K. et al. 1997. Effects of the transcendental mediation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4 months of practice. Psychoneuroendocrinology 22 : 277 295.
89. Persengiev, S.P. 1999. Multiple domains of melatonin receptor are involved in the regulation of glucocorticoid receptor-induced gene expression. J. Steroid. Biochem. Mol Biol. 68 : 181 187.
90. DeButte, M. & B.A. Pappas. 2006. Pinealectomy causes hippocampal CA1 and CA3 cell loss: reversal by melatonin supplementation. Neurobiol. Aging, Jan 10.
91. Karishma, K.K. & J. Herbert. 2002. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16 : 445 453.
92. Beary, J.F. & H. Benson. 1974. A simple psychophysiologic technique which elicits the hypometabolic changes of the relaxation response. Psychosom. Med. 36 : 115 120.
93. Hoffman, J.W., H. Benson, P.A. Arns, et al. 1982. Reduced sympathetic nervous system responsivity associated with the relaxation response. Science 215 : 190 192.
94. Wallace, R.K., H. Benson & A.F. Wilson. 1971. A wakeful hypometabolic physiologic state. Am. J. Physiol. 221 : 795 799.
95. Wallace, R.K. & H. Benson. 1972. The physiology of meditation. Sci. Am. 262 : 84 90.
96. Dillbeck, M.C. & D.W. Orme-Johnson. 1987. Physiological differences between transcendental meditation and rest. Am. Psychol. 42 : 879 881.
97. Goleman, D. & G. Schwartz. 1976. Meditation as an intervention in stress-reactivity. J. Consult. Clin. Psychol. 44 : 456 466.
98. Michaels, R.R., J. Pano, D.S. McCann & A.J. Vander. 1979. Renin, cortisol and aldosterone during transcendental meditation. Psychosom. Med. 41 : 50 54.
99. Wallace, R.K., J. Silver, P.J. Mills, et al. 1983. Systolic blood pressure and long term practice of the transcendental meditation and TM-Sidhi programs: effects of TM on systolic blood pressure. Psychosom. Med. 451 456.
100. Barnes, V.A., F.A. Treiber, J.R. Turner & H. Davis. 1999. Acute effects of transcendental meditation on hemodynamic functioning in middle-aged adults. Psychosom. Med. 61 : 525 531.
101. Wenneberg, S.R., R.H. Schneider, K.G. Walton, et al. 1997. A controlled study of the effects of the transcendental meditation program on cardiovascular reactivity and ambulatory blood pressure. Intern. J. Neurosci. 89 : 15 28.